CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
137 hedge funds and large institutions have $2.02B invested in China Biologic Products Holdings, Inc. in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 143 → 137 (-6)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
137
Holding in Top 10
4
Calls
$10.5M
Puts
$2.37M
Top Buyers
| 1 | +$132M | |
| 2 | +$40.7M | |
| 3 | +$30.2M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$27.3M |
| 5 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$26.3M |
Top Sellers
| 1 | -$97.2M | |
| 2 | -$25.7M | |
| 3 | -$24.4M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$15.8M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
-$8.52M |